Genetic and host factors for dementia in Down's syndrome

British Journal of Psychiatry

Volumn 180, Issue MAY, 2002, Pages 405-410

  Schupf, Nicole ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; ESTROGEN;

ALLELE; ALZHEIMER DISEASE; CHROMOSOME ABERRATION; DEMENTIA; DOWN SYNDROME; ESTROGEN DEFICIENCY; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; MORTALITY; NEUROFIBRILLARY TANGLE; ONSET AGE; REVIEW; RISK FACTOR; SEX DIFFERENCE;

AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; DOWN SYNDROME; ESTROGENS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SEX FACTORS;

EID: 0036261357     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.180.5.405     Document Type: Review

References (79)

1. Diagnosis of dementia in individuals with intellectual disability
2. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study
3. Estrogen replacement therapy and cognitive function in older women
4. Protective effect of apoE ε2 in Alzheimer's disease
5. Familial Alzheimer's disease-linked presenilin I variants elevate Abeta1-42/1-40 ratio in vitro and in vivo
6. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study
7. Serum gonadotrophins in Down syndrome
8. Longevity of a woman with Down syndrome: A case study
9. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
10. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease
11. Lower frequency of apolipoprotein E4 allele in an 'elderly' Down's syndrome population
12. Age at onset of dementia and age of menopause in women with Down's syndrome
13. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity
14. APOE ε4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
15. Allelic variability in D2ISII, but not in APP or APOE, is associated with cognitive decline in Down syndrome
16. Segregation of a missense mutation of the amyloid precursor protein gene with familial Alzheimer's disease
17. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons
18. ApoE genotype and Down's syndrome
19. Gonadal function in trisomy 21
20. Estrogen replacement therapy in older women
21. Estrogen for Alzheimer's disease in women: Randomized, double-blind placebo-controlled trial
22. Hormonal and biochemical disturbances in Down's syndrome
23. Presenilin-1 polymorphism and Alzheimer's disease
24. Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome
25. Gonadal function in patients with Down syndrome
26. Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome)
27. Visualization of AB42(43) and AB40 in senile plaques with end-specific AB monoclonals: Evidence that an initially deposited species is AB42(43)
28. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome
29. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein
30. Presenilin-1 polymorphism and Alzheimer's disease
31. The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)
32. A prospective study of Alzheimer disease in Down syndrome
33. APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
34. Analysis of the APOE alleles' impact in Down's syndrome
35. Candidate gene for the chromosome I familial Alzheimer's disease locus
36. Apolipoprotein E-2 and Alzheimer's disease: Genotype influences pathologic phenotype
37. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments
38. Association between Alzheimer disease and Down syndrome
39. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene
40. ApoE genotypes in Australia: Roles in early and late onset Alzheimer's disease and Down's syndrome
41. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease
42. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease
43. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease
44. Increased plasma amyloid beta protein 1-42 levels in Down syndrome
45. APOE genotype predicts when-not whether-one is predisposed to Alzheimer's disease
46. Lack of postmenopausal estrogen therapy and risk of dementia
47. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial: Alzheimer's Disease Cooperative Study
48. Correlation between elevated levels of amyloid B-peptide in the brain and cognitive decline
49. Estrogen deficiency and risk of Alzheimer's disease in women
50. Ovariectomy and 17 beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain
51. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein
52. Age of onset and duration of dementia in people with Down syndrome: Integration of 98 reported cases in the literature
53. ApoE genotype and Alzheimer's disease in adults with Down syndrome: Meta-analysis
54. Molecular mapping of Alzheimer-type dementia in Down's syndrome
55. Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)
56. Clinical application of apolipoprotein E genotyping to Alzheimer's disease
57. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia
58. ApoE genotypes and risk of dementia in Down syndrome
59. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease
60. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases
61. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
62. Onset of dementia is associated with apolipoprotein E ε4 in Down syndrome
63. Earlier onset of Alzheimer's disease in men with Down syndrome
64. Elevated plasma amyloid β-peptide 1-42 and onset of dementia in Down syndrome
65. Presenilin-1 polymorphism and Alzheimer's disease
66. Prevalence of dementia of the Alzheimer type and apolipoprotein E phenotypes in aged patients with Down syndrome
67. Cloning of a novel gene bearing missense mutations in early familial Alzheimer's disease
68. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
69. Plasma levels of amyloid β-proteins ABI-40 and ABI-42(43) are elevated in Down's syndrome
70. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain
71. A protective effect of apolipoprotein E e 2 allele on dementia in Down's syndrome
72. Presenilin 1 and alpha-1-antichymotrypsin polymorphisms in Down syndrome: No effect on the presence of dementia
73. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome
74. Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome
75. Age-associated development of diffuse and thioflavin-S-positive plaques in Down syndrome
76. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome
77. Genetic association between intronic polymorphism in presenilin-1 gene and late onset Alzheimer's disease
78. The role of A beta 42 in Alzheimer's disease
79. The epidemiology of Alzheimer disease in intellectual disability: Results and recommendations from an international conference